Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Astex Pharmaceuticals, Inc
Femme et Homme Max 99 ans
Astex Pharmaceuticals, Inc
MAJ Il y a 4 ans
A clinical trial to assess and compare overall survival (OS) between guadecitabine and treatment choice (TC) in adults with previously treated acute myeloid leukemia (AML) Un ensayo clínico para evaluar y comparar la supervivencia global entre la guadecitabina y la elección de tratamiento en adultos con leucemia mieloide aguda previamente tratada
To assess and compare overall survival (OS) between guadecitabine and treatment choice (TC) in adults with previously treated acute myeloid leukemia (AML). TC options are: • High intensity (intermed...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Astex Pharmaceuticals, Inc
MAJ Il y a 4 ans
A study to test a new product AT13387 in lung cancer. Un estudio para probar un nuevo producto AT13387 en cáncer de pulmón
Part A ?To establish the safety and maximum tolerated dose (MTD) of AT13387 when administered in combination with crizotinib. Part B ?To compare the PFS between the administration of single-agent cr...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Homme Max 99 ans
Astex Pharmaceuticals, Inc
MAJ Il y a 4 ans
A clinical trial to investigate the safety and effect of a drug called AT13387 on its own or given with another drug Abiraterone Acetate on certain types of Prostate Cancer that does not respond to treatment with Abiraterone alone
Part A: • To assess the safety and tolerability (incidence and severity of adverse events [AEs]) of the combination of AT13387 and abiraterone acetate and to select the most promising treatment regime...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme Max 99 ans
Astex Pharmaceuticals, Inc
MAJ Il y a 4 ans
A study of SGI-110 in people with recurrent ovarian cancer who are also resistant to platinum treatment
Stage 1 To assess the safety and tolerability of SGI-110+carboplatin and determine the maximum tolerated dose (MTD) for Stage 2 Stage 2 To assess and compare progression free survival (PFS) bet...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Astex Pharmaceuticals, Inc
MAJ Il y a 4 ans
A clinical trial to compare SGI-110 to other available treatments in patients with previously untreated Acute Myeloid Leukemia(AML) who are not considered suitable for intensive Chemotherapy
To assess and compare efficacy (complete response [CR] rate) and overall survival (OS) between SGI-110 and TC (treatment choice) in adults with previously untreated AML who are not considered candidat...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations